HDL and Reverse Cholesterol Transport Biomarkers

21Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

High-density lipoprotein (HDL) is a protein-lipid nanoparticle that has predominately been characterized by its cholesterol concentration (HDL-C). Recent studies have challenged the presumed inverse association between HDL-C and cardiovascular events, suggesting a more U-shaped association. This has opened new opportunities to evaluate more novel measures of HDL metabolism, such as HDL particle number (HDL-P) and one of HDL’s key functions, cholesterol efflux. Both HDL-P and cholesterol efflux are inversely associated with incident cardiovascular events and may perhaps be better targets for intervention. This review includes recent research on the emerging U-shaped association between HDL-C and cardiovascular events, recent observational studies related to HDL-P, and the effects of established and novel interventions on cholesterol efflux.

Cite

CITATION STYLE

APA

Riggs, K. A., & Rohatgi, A. (2019). HDL and Reverse Cholesterol Transport Biomarkers. Methodist DeBakey Cardiovascular Journal. Houston Methodist Debakey Heart and Vascular Center. https://doi.org/10.14797/mdcj-15-1-39

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free